Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Arrhythmia Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of arrhythmia among population and need for arrhythmia monitoring devices
5.1.1.2. Trend of irrigated radiofrequency (RF) ablation catheter devices
5.1.1.3. Rising awareness campaigns for arrhythmia
5.1.2. Restraints
5.1.2.1. High-cost associated with arrhythmia treatment and devices
5.1.3. Opportunities
5.1.3.1. Technological advancements in arrhythmia devices
5.1.3.2. Robust research activities to develop new arrhythmia treatments
5.1.4. Challenges
5.1.4.1. Limitation of holter recordings for arrhythmia monitoring
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Arrhythmia Market, by Site Of Origin Atrial
6.1. Introduction
6.2. Atrial Tachycardia
6.3. Premature Atrial Contractions
6.4. Sinus Bradycardia
6.5. Wandering Atrial Pacemaker

7. Arrhythmia Market, by Test Equipment
7.1. Introduction
7.2. Electrocardiogram
7.3. Holter Monitor

8. Americas Arrhythmia Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Arrhythmia Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Arrhythmia Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. ACS Diagnostics
12.1.3. AliveCor, Inc.
12.1.4. AtriCure Inc.
12.1.5. Biotricity
12.1.6. BIOTRONIK, Inc.
12.1.7. Boston Scientific Corporation
12.1.8. CardioFocus, Inc.
12.1.9. CathRx Ltd.
12.1.10. Fukuda Denshi
12.1.11. GE Healthcare
12.1.12. GlaxoSmithKline PLC
12.1.13. Hill-Rom Holdings, Inc
12.1.14. iRhythm Technologies Inc.
12.1.15. Koninklijke Philips NV
12.1.16. Medi-Lynx Cardiac Monitoring, LLC
12.1.17. Medtronic PLC
12.1.18. MicroPort Scientific Corporation
12.1.19. Nihon Kohden Corporation
12.1.20. Novartis AG
12.1.21. OSI Systems, Inc.
12.1.22. Sanofi S.A.
12.1.23. SCHILLER
12.1.24. Siemens Healthcare GmbH
12.1.25. St. Jude Medical, Inc.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. ARRHYTHMIA MARKET RESEARCH PROCESS
FIGURE 2. ARRHYTHMIA MARKET SIZE, 2022 VS 2030
FIGURE 3. ARRHYTHMIA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ARRHYTHMIA MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. ARRHYTHMIA MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. ARRHYTHMIA MARKET DYNAMICS
FIGURE 7. ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2022 VS 2030 (%)
FIGURE 8. ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2022 VS 2030 (%)
FIGURE 10. ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 12. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 14. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ARRHYTHMIA MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 20. ARRHYTHMIA MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. ARRHYTHMIA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. ARRHYTHMIA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ARRHYTHMIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 6. ARRHYTHMIA MARKET SIZE, BY ATRIAL TACHYCARDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ARRHYTHMIA MARKET SIZE, BY PREMATURE ATRIAL CONTRACTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ARRHYTHMIA MARKET SIZE, BY SINUS BRADYCARDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ARRHYTHMIA MARKET SIZE, BY WANDERING ATRIAL PACEMAKER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 11. ARRHYTHMIA MARKET SIZE, BY ELECTROCARDIOGRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ARRHYTHMIA MARKET SIZE, BY HOLTER MONITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 20. CANADA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 21. CANADA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 22. MEXICO ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 23. MEXICO ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES ARRHYTHMIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 32. CHINA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 33. CHINA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 34. INDIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 35. INDIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 38. JAPAN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 39. JAPAN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 50. THAILAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 51. THAILAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA ARRHYTHMIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. DENMARK ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 58. DENMARK ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 59. EGYPT ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 60. EGYPT ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 61. FINLAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 62. FINLAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 63. FRANCE ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 64. FRANCE ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 65. GERMANY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 66. GERMANY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 69. ITALY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 70. ITALY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 75. NORWAY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 76. NORWAY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 77. POLAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 78. POLAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 79. QATAR ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 80. QATAR ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 87. SPAIN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 88. SPAIN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 93. TURKEY ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 94. TURKEY ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM ARRHYTHMIA MARKET SIZE, BY SITE OF ORIGIN ATRIAL, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM ARRHYTHMIA MARKET SIZE, BY TEST EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 99. ARRHYTHMIA MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 100. ARRHYTHMIA MARKET SHARE, BY KEY PLAYER, 2022
TABLE 101. ARRHYTHMIA MARKET LICENSE & PRICING